Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Valérie, Oules"'
Autor:
Xavier, Adhoute, Marie, De Matharel, Laurent, Mineur, Guillaume, Pénaranda, Dann, Ouizeman, Clemence, Toullec, Albert, Tran, Paul, Castellani, Armelle, Rollet, Valérie, Oules, Hervé, Perrier, Si Nafa, Si Ahmed, Marc, Bourliere, Rodolphe, Anty
Publikováno v:
World Journal of Gastrointestinal Oncology. 14:1510-1527
Starting a second-line systemic treatment for hepatocellular carcinoma (HCC) is a common situation. The only therapeutic options in France are two broad-spectrum tyrosine kinase inhibitors (TKIs), regorafenib (REG) and cabozantinib (CBZ), but no comp
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 11 (2018)
The advent of oral direct-acting antiviral agents (DAAs) has dramatically improved the hepatitis C virus (HCV) treatment landscape in the last 4 years, providing cure rates over 95% with a shorter duration of treatment and a very good safety profile.
Externí odkaz:
https://doaj.org/article/5967b3b832bc4585a3dfbd429aabbd4c
Autor:
Xavier Adhoute, Hervé Perrier, P. Cassagneau, Paul Castellani, Valérie Oules, Jean-Pierre Bronowicki, Olivia Pietri, Jean-Luc Raoul, Patrick Beaurain, Olivier Monnet, Cyrille Muller, B. Pol, Guillaume Penaranda, Marc Bourlière, Olivier Bayle
Publikováno v:
European Journal of Gastroenterology & Hepatology. 31:1414-1423
BACKGROUND Conventional transarterial chemoembolization (cTACE) with lipiodol is widely performed in patients with hepatocellular carcinoma (HCC) unsuitable for curative treatment. Additional tumor parameters such as HCC macroscopic appearance based
Autor:
Paul Castellani, Marc Bourlière, Xavier Adhoute, Guillaume Penaranda, Hervé Perrier, Valérie Oules, Jean-Luc Raoul
Publikováno v:
Liver Cancer
Background: Sorafenib is the first-line treatment for advanced hepatocellular carcinoma (HCC). The management of its side effects is improving. This study aimed to assess, in real life, if this translates into a better prognosis. Methods: This was a
Autor:
Pierre Nahon, Marie Najean, Richard Layese, Kevin Zarca, Laeticia Blampain Segar, Carole Cagnot, Nathalie Ganne-Carrié, Gisèle N’Kontchou, Stanislas Pol, Cendrine Chaffaut, Fabrice Carrat, Maxime Ronot, Etienne Audureau, Isabelle Durand-Zaleski, Tarik Asselah, Dominique Guyader, Hélène Fontaine, Georges-Philippe Pageaux, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Thomas Decaensi, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Sebastien Dharancy, Jean-Frédéric Blanc, Armand Abergel, Olivier Chazouillères, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Louis d’Alteroche, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Eric Nguyen-Khac, Brigitte Bernard-Chabert, Sophie Hillaire, Vincent Di Martino, Delphine Bonnet, Virginie Payssan-Sicart, Chloe Pomes, François Bailly, Marjolaine Beaudoin, Dominique Giboz, Kerstin Hartig-Lavie, Marianne Maynard, Eric Billaud, David Boutoille, Morane Cavellec, Marjorie Cheraud-Carpentier, Isabelle Hubert, Jaouad Benhida, Adrien Lannes, Françoise Lunel, Frédéric Oberti, Nathalie Boyer, Nathalie Giuily, Corinne Castelnau, Giovanna Scoazec, Aziza Chibah, Sylvie Keser, Karim Bonardi, Anaïs Vallet-Pichard, Philippe Sogni, Juliette Foucher, Jean-Baptiste Hiriart, Amy Wilson, Sarah Shili, Faiza Chermak, Christelle Ansaldi, Nisserine Ben Amara, Laëtitia Chouquet, Emilie De Luca, Valérie Oules, Rodolphe Anty, Eve Gelsi, Régine Truchi, Elena Luckina, Nadia Messaoudi, Joseph Moussali, Barbara De Dieuleveult, Damien Labarriere, Pascal Poter, Si Nafa Si Ahmed, Véronique Grando-Lemaire, Valérie Bourcier, Séverine Brulé, Thomas Stalhberger, Caroline Jezequel, Audrey Brener, Anne Laligant, Aline Rabot, Isabelle Renard, Thomas F. Baumert, Michel Dofföel, Catherine Mutter, Pauline Simo-Noumbissie, Esma Razi, Hélène Barraud, Mouni Bensenane, Abdelbasset Nani, Sarah Hassani-Nani, Marie-Albertine Bernard, Michael Bismuth, Ludovic Caillo, Stéphanie Faure, Marie Pierre Ripault, Christophe Bureau, Jean Marie Peron, Marie Angèle Robic, Léa Tarallo, Marine Faure, Bruno Froissart, Marie-Noelle Hilleret, Jean-Pierre Zarski, Odile Goria, Victorien Grard, Hélène Montialoux, Muriel François, Christian Ouedraogo, Christelle Pauleau, Anne Varault, Tony Andreani, Bénédicte Angoulevant, Azeline Chevance, Lawrence Serfaty, Teresa Antonini, Audrey Coilly, Jean-Charles Duclos Vallée, Mariagrazia Tateo, Corinne Bonny, Chanteranne Brigitte, Géraldine Lamblin, Léon Muti, Abdenour Babouri, Virginie Filipe, Camille Barrault, Laurent Costes, Hervé Hagège, Soraya Merbah, Paul Carrier, Maryline Debette-Gratien, Jérémie Jacques, Guillaume Lassailly, Florent Artu, Valérie Canva, Sébastien Dharancy, Alexandre Louvet, Marianne Latournerie, Marc Bardou, Thomas Mouillot, Yannick Bacq, Didier Barbereau, Charlotte Nicolas, Caroline Chevalier, Isabelle Archambeaud, Sarah Habes, Danièle Botta-Fridlund, Eric Saillard, Marie-Josée Lafrance, Patrice Cacoub, Patrizia Carrieri, Elisabeth Delarocque-Astagneau, Victor De Ledinghen, Céline Dorival, Jean Dubuisson, Chantal Housset, Dominique Larrey, Patrick Marcellin, Jean-Michel Pawlotsky, Ventzislava Petrov-Sanchez, Sophie Vaux, Linda Wittkop, Yazdan Yazdanpanah, Jessica Zucman-Rossi, Christophe Moreno, Romain Moirand, Nicolas Carbonell, Jean-Charles Duclos-Vallée, Victor de Ledinghen, Violaine Ozenne, Jean Henrion, Gabriel Perlemuter, Xavier Amiot, Sylvie Chevret
Publikováno v:
JHEP Reports
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 4 (1), pp.100390. ⟨10.1016/j.jhepr.2021.100390⟩
JHEP Reports Innovation in Hepatology
JHEP Reports Innovation in Hepatology, Elsevier, 2021, 4 (1), pp.100390. ⟨10.1016/j.jhepr.2021.100390⟩
Background & Aims Reinforced hepatocellular carcinoma (HCC) surveillance using magnetic resonance imaging (MRI) could increase early tumour detection but faces cost-effectiveness issues. In this study, we aimed to evaluate the cost-effectiveness of M
Autor:
Floriane Sellier, Marc Bourlière, B. Pol, Manuela Campanile, Patrick Beaurain, Hervé Perrier, Olivier Bayle, Xavier Adhoute, Valérie Oules, G. Lefolgoc, Guillaume Penaranda, Jean-Luc Raoul, Paul Castellani, Olivier Monnet
Publikováno v:
European Journal of Gastroenterology & Hepatology. 30:368-375
BACKGROUND Direct-acting antivirals (DAAs) therapy against hepatitis C viral (HCV) infection has markedly improved the sustained viral response. However, recent studies have suggested an unsuspected high rate of hepatocellular carcinoma (HCC) recurre
Publikováno v:
La Revue du praticien. 68(3)
Hepatitis b virus infection: control or cure? Hepatitis B virus infection remains a global public health issue with changing epidemiology due to several factors including vaccination policies and migration. Approximately 254 million individuals are c
Autor:
Xavier Adhoute, Valérie Oules, Christelle Ansaldi, Astrid Wendt, Paul Castellani, Marc Bourlière
Publikováno v:
Liver International. 34:4-10
Treatment with first generation protease inhibitors (PIs) is a milestone in the history of HCV therapy. Triple therapy with boceprevir (BOC) improves sustained virological response (SVR) by 30% in treatment naïve genotype 1 patients and by 50-60% in
Autor:
Laurence Pellissier, Caroline Solas, Malika Mokhtari, Danielle Botta-Fridlund, B. Castan, M. Soavi, Rolande Cohen, Sylvie Bregigeon, Philippe Halfon, Catherine Dhiver, Isabelle Portal, Christelle Tomei, Albert Darque, Thierry Allegre, Isabelle Poizot-Martin, Patrick Philibert, Amélie Menard, Isabelle Ravaux, Jacques Moreau, Valérie Oules, Marc Bourlière, Philippe Colson
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss, Pp 9-(2016)
Autor:
Valérie Oules, Philippe Halfon, Danielle Botta, Albert Tran, Marc Bourlière, Isabelle Portal, Yaakov Maor, Christophe Renou, Laurent Argiro, Claire Wartelle, Paul Castellani, Guillaume Penaranda, Alain Dessein, Denis Ouzan
Publikováno v:
European Journal of Gastroenterology & Hepatology. 23:931-935
BACKGROUND: Recent studies have suggested that host genetics may be useful for predicting drug response and have supported the recommendation that single polynucleotide polymorphisms (SNPs) of IL28B should be investigated when treating hepatitis C vi